News, Stories and Updates from the World of Sleep
SomnusNooze Topics: Other Treatments
In Case You Missed It! – July 2019
Keep up to date with the news we’ve shared via social media in this month’s “In Case You Missed It!” URGENT: Health authorities warn that modafinil may cause fetal harm. CONGRATULATIONS: Dr. Caroline Maness of Emory University is the first... read >
WEP Clinical – Expanded Access to Medications Not Yet Approved for General Prescription
October 2019 Addendum SEE ALSO: Global Genes RARE Toolkits Access to Unapproved Medicine: Is This an Option for Me? (USA) Access to Unapproved Medicine: Is This an Option for Me? (Canada) Do you and your healthcare provider feel you... read >
Arise Clinical Trial
CLINICAL TRIAL ENROLLING PATIENTS WITH IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY TYPE 2 Balance Therapeutics is evaluating an investigational new drug BTD-001, to treat excessive daytime sleepiness in individuals diagnosed with idiopathic hypersomnia... read >
Summary of Rationale Behind and Research Studies into L-carnitine as a Treatment for Narcolepsy
Background In this 2013 study published in PLoS One, the researchers Miyagawa et al hypothesized that L-carnitine supplementation might help improve narcolepsy symptoms by increasing β-fatty-acid oxidation. Fatty acids are a major energy source for... read >
EMA Recommends Approval of Pitolisant for the Treatment of Narcolepsy
On November 20, 2015, the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended that Bioprojet Pharma's drug pitolisant (Wakix) be approved for the treatment of narcolepsy with or without cataplexy. In... read >